Previous Article | Next Article 
Journal of Bacteriology, November 1998, p. 5968-5977, Vol. 180, No. 22
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Decay of ermC mRNA in a Polynucleotide
Phosphorylase Mutant of Bacillus subtilis
David H.
Bechhofer* and
Wei
Wang
Department of Biochemistry, Mount Sinai
School of Medicine of the City University of New York, New York,
New York 10029
Received 13 August 1998/Accepted 15 September 1998
 |
ABSTRACT |
ermC mRNA decay was examined in a mutant of
Bacillus subtilis that has a deleted pnpA gene
(coding for polynucleotide phosphorylase). 5'-proximal RNA fragments
less than 400 nucleotides in length were abundant in the
pnpA strain but barely detectable in the wild type. On the
other hand, the patterns of 3'-proximal RNA fragments were similar in
the wild-type and pnpA strains. Northern blot analysis with
different probes showed that the 5' end of the decay intermediates was
the native ermC 5' end. For one prominent ermC
RNA fragment, in particular, it was shown that formation of its 3' end
was directly related to the presence of a stalled ribosome. 5'-proximal
decay intermediates were also detected for transcripts encoded by the
yybF gene. These results suggest that PNPase activity,
which may be less sensitive to structures or sequences that block
exonucleolytic decay, is required for efficient decay of specific mRNA
fragments. However, it was shown that even PNPase activity could be
blocked in vivo at a particular RNA structure.
 |
INTRODUCTION |
The ermC gene, carried on
plasmid pE194 in Bacillus subtilis, encodes an rRNA
methyltransferase (methylase) that confers resistance to erythromycin
(EM) (28). We have studied the induced stabilization of
ermC mRNA in B. subtilis, which is the result of
stalling of an EM-bound ribosome near the 5' end of the ermC
message (2, 3). The fact that a ribosome stalled near the 5'
end of ermC leader RNA protects diverse mRNA sequences from
decay (10) suggested that the decay-initiating nuclease must
access the message from the 5' end and then loop or track to an
internal cleavage site. Cleavage at an internal site initiates decay by
generating (i) an upstream RNA fragment with an unprotected 3' end that
is degraded by a 3'-to-5' exonuclease and (ii) a downstream RNA
fragment with a free 5' end, which is accessible to the
decay-initiating nuclease, leading to another round of internal
cleavage and degradation (1). It has been proposed for
Escherichia coli mRNA that decay from the 3' end formed by
rho-independent termination is blocked by the 3'-terminal stem-loop
structure (4), perhaps in conjunction with the binding of an
exonuclease-impeding factor (8).
Intermediates in ermC mRNA decay in B. subtilis
have been difficult to characterize by Northern blot analysis.
Apparently, once decay is initiated, the subsequent steps in the decay
process are rapid. A detailed analysis of pur operon mRNA
decay intermediates was possible because of the high degree of
stability of these intermediates (15). Recently, decay
intermediates of the Bacillus thuringiensis cry1Aa message,
expressed in B. subtilis, was reported (30).
Initiation of decay of cry1Aa mRNA was suggested to occur by
endonuclease cleavages in specific 5' and 3' regions.
We have constructed a B. subtilis strain that contains a
deletion in the pnpA gene, which codes for polynucleotide
phosphorylase (PNPase) (32). In an earlier report, Deutscher
and Reuven (9) used 3H-labeled poly(A) as a
substrate to demonstrate that the phosphorolytic activity of PNPase is
the major 3'-to-5' exonucleolytic activity in B. subtilis
unlike the case in E. coli, where PNPase
activity contributed only 10% of the exonucleolytic activity, and the
major exonucleolytic activity was that of RNase II, a hydrolytic
enzyme. We had expected, therefore, that disruption of the
pnpA gene would have a major effect on the growth of
B. subtilis, as disruption of 3'-to-5' exonuclease activity
in E. coli (by mutations in the RNase II- and
PNPase-encoding genes) results in cell death (11). In fact,
the B. subtilis pnpA deletion strain was not only viable but
grew almost as well as the wild type at 37°C (32). Assays of bulk mRNA decay showed little difference between the wild-type and
pnpA mutant strains. An exonuclease whose in vitro activity is enhanced in the presence of Mn2+ appeared to compensate
for the lack of PNPase activity in this strain. The observable
phenotypes of the pnpA strain were filamentous growth, cold
sensitivity, and inability to grow in low levels of tetracycline.
Despite the modest effect of the absence of PNPase on bulk mRNA decay,
we hypothesized that an examination of specific mRNAs in the
pnpA mutant strain might allow observation of decay
intermediates that are normally degraded rapidly. We show here that
decay intermediates of ermC mRNA can be readily detected in
the pnpA mutant strain.
 |
MATERIALS AND METHODS |
Bacterial strains.
The wild-type B. subtilis host
was BG1, which is trpC2 thr-5. The pnpA mutant
host was BG119, a derivative of BG1 in which an internal portion of the
pnpA gene was replaced with a kanamycin resistance cassette
(32). The preparation of B. subtilis growth media
and competent B. subtilis cultures was done as previously described (14). E. coli DH5
(16)
was the host for plasmid constructions.
Plasmids.
The pnpA gene was reintroduced into the
pnpA mutant strain by cloning into
ermC-containing plasmid pYH30, which is a cointegrate of
pGEM-3Zf(+) (Promega) and pBD144 joined at their unique PstI sites. Plasmid pBD144 is a pE194 derivative that carries the
chloramphenicol resistance marker of pC194 on a ClaI
fragment. An XbaI fragment from plasmid pNP7
(32), which carries the pnpA gene under control of the ermC promoter, was inserted into the unique
XbaI site of pYH30.
The plasmid carrying wild-type ermC was pBD404, which is a
cop-1 version of pBD144 that has a copy number of 200/cell
(31). The ermC deletion derivatives used in the
experiment shown in Fig. 6 were constructed by introducing
via
oligonucleotide mutagenesis
an additional HpaI site into
the ermC coding sequence, upstream of the HpaI
site that is located 200 bp from the end of the ermC coding
sequence (see Fig. 6). The internal HpaI fragment thus created was deleted, giving rise to various-size deletions of the
ermC gene. The recipient plasmid for these deletions was
pYH40 (19), which has a pE194 replicon (i.e., a copy number
of 10 to 20/cell). Mutagenesis was done by the method of Kunkel et al. (21).
The
ermC plasmids with leader regions containing either no
insert, a 9-nucleotide (nt) insert, or an 18-nt insert carried
in
pnpA mutant strains BE514, BE503, and BE504, respectively
(see
Fig.
7), were the same plasmids as those carried in wild-type
strains BE177, BE207, and BE218, as described previously
(
18).
The SP82-
ermC sequence, which was transcribed to give the
RNA shown in Fig.
8, was constructed as follows. The
HpaI-
HindIII
fragment of EG242, which
contains the SP82
B. subtilis RNase III
(Bs-RNase III) A
cleavage site in an M13 vector (
26), was replaced
with an
HpaI-
HindIII fragment containing the
3'-terminal 200 bp
of the
ermC transcriptional unit. The
fused SP82-
ermC sequence
was amplified by PCR, with the
upstream primer providing an
AflIII
site such that the
amplicon could be cloned between the
NcoI and
HindIII sites of pYH40 (
19). The resulting
plasmid, pYH188,
was used to transform
BG119.
The cloned
B. subtilis genomic DNA containing
yybF sequences was initially isolated on plasmid pTCC1,
which was selected from
a
B. subtilis genomic library
(kindly provided by A. D. Grossman)
by virtue of its ability to
complement the tetracycline sensitivity
of BG119. The cloned
B. subtilis fragment in pTCC1 was recloned
as an
SmaI-
HindIII fragment into
HpaI-
HindIII-digested pYH25,
which is a
cointegrate of pGEM-3Zf(+) (Promega) and pBD144 joined
at their unique
PstI sites. The plasmid pYH25 derivative with
the pTCC1
fragment inserted was named pTCC1-25. To reintroduce
the
pnpA gene into the
pnpA strain, an
XbaI fragment of pNP7 (
32),
which carries the
pnpA gene under control of the
ermC promoter,
was
inserted into the unique
XbaI site of pTCC1-25 to give
plasmid
pNP15.
RNA analysis.
Strains were grown in enriched minimal medium
until late logarithmic phase, and RNA was isolated as described
previously (2). Enriched minimal medium contained 1×
Spizizen salts with 0.5% glucose, 0.1% Casamino Acids, 0.001% yeast
extract, 50-µg/ml (each) tryptophan and threonine, and 1 mM
MgSO4. Northern blot analysis, using formaldehyde-agarose
gels or 6% denaturing polyacrylamide gels, was done as described
previously (33). Radioactivity in the bands on Northern
blots was quantitated by using a PhosphorImager instrument (Molecular
Dynamics). Half-lives were determined by linear regression analysis on
semilogarithmic plots of percent RNA remaining versus time.
 |
RESULTS |
Detection of ermC mRNA decay products.
Since much
of our work on mRNA decay in B. subtilis has been concerned
with the 910-nt mRNA encoded by the ermC gene,
ermC mRNA was examined in the pnpA background.
Steady-state RNA was isolated from wild-type and pnpA
strains carrying the ermC gene. The RNA was separated in a
formaldehyde-agarose gel, and Northern blot analysis was performed by
using a 5'-end-labeled oligonucleotide probe that was complementary to
nt 10 to 27 of the ermC transcriptional unit (Fig.
1C). A difference in the pattern of
ermC-specific RNA was observed in these strains (Fig.
2A, lanes 1 and 2). In the wild type,
primarily the full-length ermC mRNA was detected, whereas in
the pnpA strain, a smear of smaller RNAs was apparent. To
demonstrate that these smaller RNAs arise due to the absence of PNPase,
the ermC plasmid was constructed to contain also the
pnpA ribosome binding site (RBS) and coding sequence
transcribed from an ermC promoter. The pattern of
ermC mRNA in the pnpA strain carrying this
pnpA-containing plasmid was similar to that in the wild type (Fig. 2A, lanes 1 and 3). Thus, the detection of ermC RNA
fragments in the pnpA mutant is enabled by the absence of
PNPase activity.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Diagrams of the ermC gene, ermC
mRNA, and hybridization probes. (A) Hatched boxes represent the
ermC leader peptide coding sequence and methylase coding
sequence. The thin arrow indicates the location of the transcriptional
start site. Relevant restriction sites are shown. (B) RBS1 and RBS2 are
indicated by filled boxes. The site of ribosome stalling is indicated
by the open box. Leader region RNA is shown schematically in the
predicted stem-loop structure for the uninduced state (17,
23). The various portions of the ermC mRNA are not
drawn to scale. (C) Probes used for Northern blot analysis.
Transcription of the indicated DNA fragments generated the 5' and 3'
riboprobes, which were uniformly labeled. The stippled bar represents
the 5' oligonucleotide probe, and the 5'-end label is indicated by the
asterisk.
|
|

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 2.
Northern blot analysis of steady-state ermC
mRNA in wild-type and pnpA strains. (A) Formaldehyde-agarose
gel, probed with the end-labeled 5' oligonucleotide probe. RNA was
isolated from the wild type (lane 1), the pnpA strain (lane
2), and the pnpA strain with the cloned pnpA gene
(lane 3). (B) Denaturing 6% polyacrylamide gels probed with the
end-labeled 5' oligonucleotide probe or the 5' riboprobe, as indicated.
The migration of full-length (FL) ermC mRNA and bands of
approximately 165 and 110 nt is indicated on the right. The marker lane
(M) contained 5'-end-labeled DNA fragments of TaqI-digested
plasmid pSE420 (5). The values to the left are molecular
sizes in nucleotides.
|
|
To further explore the nature of the
ermC RNA fragments, the
same RNA preparations were separated in a denaturing 6% polyacrylamide
gel, electroblotted, and probed with both the 5'-end-labeled
oligonucleotide
and an
ermC 5' riboprobe that was
complementary to the first 360
nt of the
ermC
transcriptional unit (Fig.
1C). The Northern blot
analyses using these
probes are shown in Fig.
2B. The
ermC RNAs
detected by the
oligonucleotide probe appeared to be identical
to those detected by the
5' riboprobe. In experiments using shorter
run times for the gels, a
group of bands of approximately 45 nt
was also detected (data not
shown). Since the oligonucleotide
probe was complementary to the
5'-terminal sequence, any RNAs
detected by this probe must have as
their 5' end the native
ermC transcriptional start site. A
previous reverse transcriptase analysis
of
ermC mRNA did not
detect any additional 5' ends near the major
transcriptional start site
(
3). Thus, the absence of PNPase
allowed detection of RNA
fragments whose 5' end was at the
ermC transcriptional start
site and whose sizes ranged from about 40
nt to about 400
nt.
Accumulation of small ermC RNA products in the
pnpA strain.
We hypothesized that the ermC
RNA fragments that were readily detectable in the pnpA
strain were decay intermediates that accumulated because of the absence
of PNPase. The stability of these RNA fragments was measured by
Northern blot analysis of RNA samples taken at various times after
addition of rifampin and separated on a formaldehyde-agarose gel. The
result (Fig. 3A) shows that small
ermC RNA fragments are stabilized in the pnpA
strain. While the half-life of the full-length ermC mRNA was
2.5 to 3 min, the smear of small RNAs was quite stable. This experiment
was repeated by using a denaturing 6% polyacrylamide gel and
electroblotting to resolve the small RNAs (Fig. 3B). In the latter
experiment, the measured half-life of full-length ermC mRNA
was 3.5 min, while the prominent bands running at about 165 and 110 nt
had a half-life of greater than 20 min. RNAs in the 300- to 400-nt
range had half-lives of 5 to 6 min. Some of the accumulated small RNAs
could come from continued breakdown of larger RNAs after rifampin
addition. In fact, there appears to be a slight increase in the amount
of small RNAs running above the 165-nt band and of the 110-nt band
until 7.5 min after rifampin addition. However, the amount of 165- and
110-nt RNA fragments that is still present at 20 min after rifampin
addition (i.e., 12.5 min after the noted accumulation at 7.5 min)
suggests that these fragments are much more stable than full-length
ermC mRNA, which is almost completely degraded in 12.5 min.
We propose that the ability to detect small ermC RNAs in the
pnpA strain is due to the stability of these fragments.
Presumably, these RNAs are degraded rapidly in the wild type by PNPase
and are thus not readily detectable.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analysis of ermC mRNA decay
after rifampin addition. Total RNA from the pnpA strain was
separated on a formaldehyde-agarose gel (A) and on a denaturing 6%
polyacrylamide gel (B). The probe was the end-labeled 5'
oligonucleotide probe. Above each lane is the time (minutes) after
rifampin addition. Full-length (FL) ermC mRNA, prominent
small RNAs, and marker bands are indicated as in Fig. 2. Molecular
sizes (in nucleotides) are shown on the left.
|
|
3'-specific ermC probe.
The patterns of RNA
fragments in the wild-type and pnpA mutant strains were also
analyzed with a riboprobe complementary to the 3'-terminal 200 nt of
ermC mRNA, and the results were compared with the results
obtained by using a 5' riboprobe (Fig.
4A). Unlike those detected with the 5'
probe, the patterns of steady-state RNA detected by the 3' probe were
virtually identical in the wild-type and pnpA strains.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Northern blot analysis of ermC mRNA with
5' and 3' riboprobes. RNA was isolated from wild-type (+) and
pnpA ( ) strains and separated on a denaturing 6%
polyacrylamide gel. (B) Northern blot analysis of ermC mRNA
decay after rifampin addition, using the 3' riboprobe. Above each lane
is the time (minutes) after rifampin addition. FL, full-length
ermC mRNA. Molecular sizes (in nucleotides) are shown on the
left.
|
|
To analyze the decay of 3'-proximal fragments, the same RNA samples
that were isolated after rifampin addition and probed
with the 5'
oligonucleotide probe (Fig.
3B) were probed with the
3' riboprobe (Fig.
4B). In striking contrast to the results obtained
with the 5' probe, no
stable decay intermediates were detected
with the 3' probe. The
half-lives of prominent RNA fragments of
about 750 and 450 nt were
similar to that of the full-length
ermC mRNA. Thus, the
absence of PNPase affects the degradation of RNA
sequences that are in
the upstream half of
ermC mRNA but not that
of RNA sequences
that are 3'
proximal.
Detection of small RNAs upon induction of ermC mRNA
stability.
Induction of ermC gene expression by EM is
accompanied by a 20-fold increase in ermC mRNA stability
(2). Stability is thought to be the result of EM-induced
ribosome stalling near the 5' end of ermC mRNA, which
protects against initiation of decay (3). To examine the
effect of induced stability on the pattern of 5'-proximal RNA
fragments, total RNA was isolated from wild-type and pnpA mutant strains in the presence and absence of EM and examined by using
the 5' oligonucleotide probe. The results (Fig.
5) show that induced stability of
full-length ermC mRNA occurs in both strains. Nevertheless,
despite the induced stability in the pnpA strain,
5'-proximal RNA decay intermediates were detected in the presence of
EM, as they were in the absence of EM.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 5.
Northern blot analysis of RNAs from the wild type
(pnpA+) and the pnpA strain
(pnpA) in the absence ( Em) and presence (+Em) of EM. RNA
was separated on a formaldehyde-agarose gel and probed with the 5'
oligonucleotide probe. Aberrant running of the RNA on the gel caused
the small fragments in the pnpA, EM lanes to appear larger
than the small fragments in the neighboring +Em lanes, but they are the
same in size. Above each lane is the time (minutes) after rifampin
addition.
|
|
mRNA decay intermediates from ermC deletion
derivatives.
The effect of ermC transcript size on the
formation of decay intermediates was tested by examining RNAs encoded
by ermC deletion derivatives. The deletion derivatives used
encoded ermC RNAs of 630, 500, and 405 nt (wild-type
ermC mRNA = 910 nt; Fig.
6). (The leader region of the
ermC gene used to construct these deletion derivatives is
missing 42 nt of the wild-type ermC leader region; therefore, the pattern of decay intermediates differs from that of the
wild type. However, induced ermC mRNA stability and
methylase expression are normal.) In all cases, the deleted coding
sequence retained the same reading frame. RNA was isolated either in
the absence of EM or 15 min after addition of EM (inducing conditions). The results (Fig. 6) show that small RNA products were virtually undetectable in the wild-type strain but were prominent in the pnpA strain. A reduction in size to half the length of
wild-type ermC RNA (pYH146) did not significantly affect the
production of decay intermediates. The patterns obtained from all three
deletion derivatives were similar, except for a missing 250-nt band in the strain carrying pYH146. Presumably, the RNA sequence that causes
this 250-nt RNA fragment to form (e.g., an endonuclease cleavage site
or a block to 3'-to-5' exonuclease degradation) was deleted in this
case. Decay intermediates were present in similar amounts whether in
the presence or in the absence of EM; however, there was one
particularly prominent band of about 80 nt that was observed only in
the presence of EM.

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 6.
Northern blot analysis of decay intermediates from
ermC deletion derivatives. Schematic diagrams of the
deletion-containing ermC genes used in the analysis are
presented at the top. Plasmid numbers in the pYH series are indicated,
and they correspond to the numbers above the lanes at the bottom. RNAs
were isolated from the wild type (pnpA+) and
from the pnpA mutant strain (pnpA) in the absence
( ) or presence (+) of EM. The thin arrow at the right shows the
250-nt band that was absent in the pYH146-carrying strain. The thick
arrow points to the prominent 80-nt band that was observed only in the
presence of EM. Molecular sizes (in nucleotides) are shown at the
left.
|
|
Blockage of 3'-to-5' exonuclease activity by a stalled
ribosome.
We investigated further the origin of the 80-nt band
that was detected only when EM was present. In the translational
attenuation model of induction of ermC expression, addition
of EM results in stalling of an EM-bound ribosome in the leader peptide
coding sequence (Fig. 1B). Ribosome stalling results in a change of
ermC leader RNA secondary structure, allowing high-level
translation from RBS2 (12, 34). Changing the second leader
peptide codon to a stop codon abolishes ermC induction,
since the EM-bound ribosome cannot reach its stalling site
(13). We determined that the prominent band observed in the
presence of EM was not observed from RNA of an ermC leader
region mutant in which the second codon was changed to a stop codon
(data not shown), suggesting that this induced RNA fragment was a
consequence of ribosome stalling.
Formation of this RNA fragment could be due to a change in the pattern
of RNA decay caused by an altered leader region RNA
structure or to the
presence of a stalled ribosome itself. To
test these possibilities, we
analyzed RNA decay intermediates
from two
ermC leader region
insertion mutations (
18), which
are derivatives of the
ermC-containing plasmid carried in strain
BE514 (partial
leader region sequences are shown in Fig.
7). The
first of these insertion
mutations (carried in strain BE503) contained
a 9-nt insert in the
ermC leader region. This insert does not
change the sequence
of amino acids at which the ribosome stalls;
however, the stalling site
is 9 nt farther away from the 5' end
than in the wild type. In the
second of these constructs (carried
in strain BE504), an additional
9-nt insert was made such that
a ribosome stalling site was created at
the same distance from
the 5' end as in the wild type but upstream of
the leader region
secondary structure (Fig.
7 contains a comparison of
ribosome
stall sites in the wild type and two mutant constructs). It
was
shown previously (
18) that although EM-induced ribosome
stalling
occurs in both of these constructs, only the construct carried
in strain BE503 is inducible for gene expression (i.e., addition
of EM
results in an increase in methylase translation due to the
change in
leader region structure caused by ribosome stalling).
The construct
carried in strain BE504 is not inducible because
the ribosome stalls
upstream of the stem-loop structure. Thus,
in strain BE504, induced
ribosome stalling occurs without the
induced change in leader region
structure.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 7.
ermC leader region insertion mutations.
Partial leader region sequences are shown. A sequence with no insert
was carried in strain BE514. The sequences of insertions in the
plasmids carried in strains BE503 and BE504 are indicated by dotted
underlining. The thick line next to the sequence shows the predicted
position of ribosome stalling in the presence of EM. At the right is
the Northern blot analysis of ermC RNAs detected in these
strains. The arrow at the right points to the prominent band induced in
the presence of EM. Molecular sizes (in nucleotides) are shown on the
left.
|
|
Northern blot analysis of
ermC RNA from the wild type and
two mutant constructs is shown on the right of Fig.
7. Decay
intermediates
from strain BE503, including the prominent EM-induced
band, were
clearly shifted relative to BE514, as was expected to occur
due
to the presence of the 9-nt insert. In the case of BE504, however,
although the additional 9-nt insert caused all of the other bands
to
shift up, the prominent EM-induced band migrated the same distance
as
in the wild type. Since ribosome stalling in strain BE504 occurs
at the
same distance from the 5' end as in the wild type, and
an induced
change in leader region structure does not occur, these
data indicate
strongly that the prominent band seen in the presence
of EM is due to
ribosome stalling
itself.
Block to PNPase processivity in vivo.
One explanation for the
decay intermediates observed in the pnpA strain is that
these RNA fragments arise because of an inability of exonucleases other
than PNPase to degrade past certain structural or sequence elements. In
the wild type, PNPase attacks such RNA fragments and rapidly finishes
the degradation process. The processivity of PNPase may be greater than
that of any other exonuclease(s) involved in ermC mRNA
decay. To test whether even PNPase activity might be blocked at
particular sites in vivo, we used a substrate that had been
characterized previously in vitro (26). We reported that a
particular bacteriophage SP82 RNA sequence, which includes a Bs-RNase
III cleavage site, contained a strong stem-loop structure that blocked
B. subtilis and E. coli PNPase processivity in
vitro. This SP82 sequence was cloned upstream of the 3'-terminal 200-nt segment of ermC, such that it could be transcribed in vivo
to give SP82-ermC RNA (Fig.
8). Northern blot analysis was performed on RNAs isolated from the wild-type and pnpA strains. Probes
complementary to the full-length RNA and to the 5' and 3' RNA fragments
generated by Bs-RNase III cleavage were used to determine the
identities of the various bands that were detected. By using the 5'
probe, a smear of hybridizing material, running below the 77-nt marker band, was detected in the wild type. Based on our previous in vitro
work (26), this smear was at the expected position for RNA
fragments that arise because of a block to PNPase degradation, which
initiates at the 3' end left by Bs-RNase III cleavage. In the
pnpA strain, this smear was not observed, and the fragment representing the 5' product of Bs-RNase III cleavage was more intense
than in the wild type. Thus, we could observe a block to PNPase
activity in the wild-type strain.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 8.
Analysis of SP82-ermC RNA. On the left, a
schematic diagram of SP82-ermC RNA is shown, indicating the
site of Bs-RNase III cleavage and the block to PNPase decay. Three
probes were used to identify RNA species encoded by the
SP82-ermC construct. The full-length (FL) probe detects four
major species, one of which is the full-length RNA. The 5' and 3'
fragments generated by Bs-RNase III cleavage are designated 5' BSR and
3' BSR, respectively. RNAs were isolated from the wild type (+) and the
pnpA mutant strain ( ). Molecular sizes (in nucleotides)
are shown on the left.
|
|
Accumulation of 5'-proximal RNA fragments from a native B. subtilis gene.
To determine whether accumulation of
5'-proximal fragments was unique to ermC, the steady-state
pattern of RNA fragments was examined for the B. subtilis
yybF gene. The N-terminal half of the yybF gene was
cloned in a screen for B. subtilis DNA fragments that could
complement the tetracycline-sensitive phenotype of the pnpA
strain (33a). A plasmid carrying the yybF gene
fragment, designated pTCC1-25 (TCC = tetracycline complementing),
was used to transform the wild-type and pnpA mutant strains.
A clear difference between the wild-type and pnpA strains,
with respect to the accumulation of small RNA fragments, was observed
upon Northern blot analysis (Fig. 9). The
probe used was complementary to sequences near the 5' end of the
yybF transcriptional unit, which was mapped by reverse transcriptase analysis. Several prominent RNA bands were observed in
the pnpA strain that were not present in the wild type (Fig. 9, lanes 1 and 2). To demonstrate that the presence of these bands in
the pnpA strain was due specifically to the absence of
PNPase activity, the pnpA coding region, transcribed from an
ermC promoter, was cloned into the pTCC1-25 plasmid.
Addition of the wild-type pnpA gene resulted in the absence
of the prominent small RNA fragments in the pnpA strain
(Fig. 9, lane 4). Thus, 5'-proximal yybF RNA fragments
accumulated in the pnpA strain due to the loss of
pnpA expression.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 9.
Northern blot analysis of yybF RNA using a 5'
yybF riboprobe. RNAs were isolated from the following: lane
1, wild type transformed with pTCC1-25; lane 2, pnpA strain
transformed with pTCC1-25; lane 3, wild type transformed with pNP15 (=
pTCC1-25 with the pnpA gene); lane 4, pnpA mutant
strain transformed with pNP15. The arrows on the right point to
prominent RNAs detected in the pnpA strain but not in the
wild-type or pnpA-complemented strain. Molecular sizes (in
nucleotides) are shown on the left.
|
|
 |
DISCUSSION |
The experiments described in this paper represent, to our
knowledge, the first reported analysis of a specific mRNA in an RNase
mutant of B. subtilis. The surprisingly healthy phenotype of
the pnpA deletion strain (32) indicated that mRNA
decay was not severely affected in this strain, despite earlier reports that PNPase was the major 3'-to-5' exoribonuclease in B. subtilis (9). Measurements of bulk mRNA decay in the
pnpA mutant showed only a slight difference from the
wild-type decay (32). Nevertheless, the probing of
ermC mRNA described here demonstrated a marked accumulation,
in the pnpA strain, of what appear to be mRNA decay intermediates. In the case of yybF RNA, as well, 5'-proximal
RNA decay intermediates were readily apparent in the pnpA
strain (Fig. 9). There is no obvious similarity between the 5'-proximal
sequences or structures of these two mRNAs that would suggest that they belong to a unique class of messages. However, since only these two
mRNAs have been analyzed so far in the pnpA strain, we do not know whether our results indicate a general accumulation of 5'-proximal RNA fragments. If so, we would have to explain why measurements of bulk mRNA decay did not show a greater difference between the pnpA mutant and the wild type. Perhaps much of
the accumulated RNA in the pnpA strain consists of
relatively small fragments, and it is possible that our assay for bulk
mRNA decay (measuring trichloroacetic acid-soluble counts) could not
differentiate between these products and oligonucleotide decay products
in the wild type.
How are the 5'-proximal RNA fragments generated? Two possibilities can
be proposed. (i) The observed decay intermediates may be the result of
a block to processivity of a 3'-to-5' exonuclease activity (other than
PNPase). This 3'-to-5' exonuclease activity may initiate at the native
3' end or at a 3' end generated by internal cleavage. (ii) The observed
decay intermediates may be the 5' fragments produced by endonucleolytic
cleavages in the upstream half of ermC mRNA.
The pattern of the smaller RNA fragments that were separated on
denaturing 6% polyacrylamide gels, in which there were many closely
spaced bands, suggests a block to 3'-to-5' exonuclease activity. This
pattern is similar to what we have observed in vitro when labeled RNA
was subjected to 3'-to-5' exonucleolytic processing and the nuclease
activity was blocked at a particular site (26). The role of
PNPase could be to degrade RNA fragments which are left after blocks to
the processivity of other exonucleases. In a comparison of in vitro
activities of E. coli RNase II and PNPase, it was shown that
PNPase was less sensitive to stem-loop structure than was RNase II
(24). The facts that the 3' riboprobe did not detect a
difference between the wild-type and pnpA strains (Fig. 4A)
and did not detect stable decay intermediates (Fig. 4B) suggest that
degradation of the 3' region of ermC mRNA proceeds without
the involvement of PNPase.
Experiments aimed at identifying the prominent band observed in the
presence of EM (Fig. 6 and 7) are also consistent with a block to
3'-to-5' exonuclease activity. The simplest interpretation of our
results is that the stalled ribosome acts as a barrier to 3'-to-5'
exonucleolytic decay. (An unlikely alternative is that there is a
specific endonuclease cleavage immediately downstream of the stalled
ribosome.) It is not clear, however, whether the size of this band can
be used to locate the leading edge of the stalled ribosome. The block
to exonuclease digestion could occur some distance away from the edge
of the ribosome. Experiments using endonucleolytic enzymes to digest
ribosome-bound poly(U) found a protected size of 49 nt, with a distance
of 23 nt from the ribosomal A site to the downstream edge
(20). However, for similar experiments done 30 years ago,
which used RNase II rather than endonucleases to digest the poly(U), a
protected size of over 100 nt was reported (7). In any
event, the absence of this prominent band in the wild type indicates
that even a stalled ribosome is not a barrier to PNPase processivity.
Nevertheless, we found that the SP82 RNA could block PNPase
processivity in vivo (Fig. 8). It will be of interest to determine what
features of this structure, which was previously determined by
structure-specific RNase analysis (26), result in a block to
PNPase processivity.
Although the simplest interpretation of our results is that the
observed 5'-proximal fragments are normally degraded by PNPase itself,
it may be that rapid and complete degradation of these fragments in the
wild type is not due to PNPase directly. Rather, the activity of some
other exonuclease may be affected by the presence or absence of PNPase,
e.g., if this exonuclease and PNPase were in a complex similar to the
degradosome of E. coli (6, 25, 27).
Multiple RNA fragments could also be the result of multiple
endonucleolytic cleavages along the message or a single cleavage that
gives rise to multiple bands by subsequent processing. Kennell and
colleagues have argued that broad-specificity endoribonucleases are
most likely to be responsible for mRNA degradation (29). In
fact, Kennell's group identified an intracellular, pyrimidine-specific endoribonuclease of B. subtilis, which was named RNase C
(22). If endonuclease cleavage is responsible for the
observed RNA fragments, then it should be possible to use reverse
transcriptase analysis to map the 5' ends of downstream cleavage
products. Experiments with even smaller ermC derivatives,
which should give a less complex pattern of decay intermediates, are
currently in progress to address this point.
The process by which 5'-proximal ermC RNA fragments are
generated will be highly relevant to understanding the mechanism of EM-induced ermC mRNA stability. Despite induced stability of
the full-length message, a similar amount of 5'-proximal
ermC RNA decay intermediates was found in the
pnpA strain, whether or not EM was added (Fig. 5). If
EM-induced ribosome stalling protects against decay-initiating events,
we would have expected to see very little of these decay intermediates
in the presence of EM. However, the observed RNA fragments could
represent stable, preexisting decay intermediates that are still not
degraded 15 min after addition of EM. Experiments with an
ermC gene whose transcription is inducible will clarify
whether ribosome stalling prevents formation of the decay intermediates.
 |
ACKNOWLEDGMENT |
This work was supported by Public Health Service grant GM-48804
from the National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, Mount Sinai School of Medicine of the City University of New York, New York, NY 10029. Phone: (212) 241-5628. Fax: (212) 996-7214. E-mail: dbechho{at}smtplink.mssm.edu.
 |
REFERENCES |
| 1.
|
Bechhofer, D. H.
1993.
5' stabilizers, p. 31-52.
In
J. Belasco, and G. Brawerman (ed.), Control of messenger RNA decay. Academic Press, Inc., New York, N.Y.
|
| 2.
|
Bechhofer, D. H., and D. Dubnau.
1987.
Induced mRNA stability in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
84:498-502[Abstract/Free Full Text].
|
| 3.
|
Bechhofer, D. H., and K. Zen.
1989.
Mechanism of erythromycin-induced ermC mRNA stability in Bacillus subtilis.
J. Bacteriol.
171:5803-5811[Abstract/Free Full Text].
|
| 4.
|
Belasco, J. G.
1993.
mRNA degradation in prokaryotic cells: an overview, p. 3-12.
In
J. Belasco, and G. Brawerman (ed.), Control of messenger RNA decay. Academic Press, Inc., New York, N.Y.
|
| 5.
|
Brosius, J.
1992.
Compilation of superlinker vectors.
Methods Enzymol.
216:469-483[Medline].
|
| 6.
|
Carpousis, A. J.,
G. Van Houwe,
C. Ehretsmann, and H. M. Krisch.
1994.
Copurification of E. coli RNase E and PNPase: evidence for a specific association between two enzymes important in RNA processing and degradation.
Cell
76:889-900[Medline].
|
| 7.
|
Castles, J. J., and M. F. Singer.
1969.
Degradation of polyuridylic acid by ribonuclease II: protection by ribosomes.
J. Mol. Biol.
40:1-17[Medline].
|
| 8.
|
Causton, H.,
B. Py,
R. S. McLaren, and C. F. Higgins.
1994.
mRNA degradation in Escherichia coli: a novel factor which impedes the exoribonucleolytic activity of PNPase at stem-loop structures.
Mol. Microbiol.
14:731-741[Medline].
|
| 9.
|
Deutscher, M. P., and N. B. Reuven.
1991.
Enzymatic basis for hydrolytic versus phosphorolytic mRNA degradation in Escherichia coli and Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
88:3277-3280[Abstract/Free Full Text].
|
| 10.
|
DiMari, J. F., and D. H. Bechhofer.
1993.
Initiation of mRNA decay in Bacillus subtilis.
Mol. Microbiol.
7:705-717[Medline].
|
| 11.
|
Donovan, W. P., and S. R. Kushner.
1986.
Polynucleotide phosphorylase and ribonuclease II are required for cell viability and mRNA turnover in Escherichia coli K-12.
Proc. Natl. Acad. Sci. USA
83:120-124[Abstract/Free Full Text].
|
| 12.
|
Dubnau, D.
1984.
Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.
Crit. Rev. Biochem.
16:103-132[Medline].
|
| 13.
|
Dubnau, D.
1985.
Induction of ermC requires translation of the leader peptide.
EMBO J.
4:533-537[Medline].
|
| 14.
|
Dubnau, D., and R. Davidoff-Abelson.
1971.
Fate of transforming DNA following uptake by competent Bacillus subtilis. I. Formation and properties of the donor-recipient complex.
J. Mol. Biol.
56:209-221[Medline].
|
| 15.
|
Ebbole, D. J., and H. Zalkin.
1988.
Detection of pur operon-attenuated mRNA and accumulated degradation intermediates in Bacillus subtilis.
J. Biol. Chem.
263:10894-10902[Abstract/Free Full Text].
|
| 16.
|
Grant, S. G. N.,
J. Jessee,
F. R. Bloom, and D. Hanahan.
1990.
Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants.
Proc. Natl. Acad. Sci. USA
87:4645-4649[Abstract/Free Full Text].
|
| 17.
|
Gryczan, T. J.,
G. Grandi,
J. Hahn,
R. Grandi, and D. Dubnau.
1980.
Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance.
Nucleic Acids Res.
8:6081-6097[Abstract/Free Full Text].
|
| 18.
|
Hue, K. K., and D. H. Bechhofer.
1991.
Effect of ermC leader region mutations on induced mRNA stability.
J. Bacteriol.
173:3732-3740[Abstract/Free Full Text].
|
| 19.
|
Hue, K. K.,
S. D. Cohen, and D. H. Bechhofer.
1995.
A polypurine sequence that acts as a 5' mRNA stabilizer in Bacillus subtilis.
J. Bacteriol.
177:3465-3471[Abstract/Free Full Text].
|
| 20.
|
Kang, C., and C. R. Kantor.
1985.
Structure of ribosome-bound messenger RNA as revealed by enzymatic accessibility studies.
J. Mol. Biol.
181:241-251[Medline].
|
| 21.
|
Kunkel, T. A.,
K. Bebenek, and J. McClary.
1991.
Efficient site-directed mutagenesis using uracil-containing DNA.
Methods Enzymol.
204:125-139[Medline].
|
| 22.
|
Mathur, S.,
V. J. Cannistraro, and D. Kennell.
1993.
Identification of an intracellular pyrimidine-specific endoribonuclease from Bacillus subtilis.
J. Bacteriol.
175:6717-6720[Abstract/Free Full Text].
|
| 23.
|
Mayford, M., and B. Weisblum.
1985.
Messenger RNA from Staphylococcus aureus that specifies macrolide-lincosamide-streptogramin resistance: demonstration of its conformation and of the leader peptide it encodes.
J. Mol. Biol.
185:769-780[Medline].
|
| 24.
|
McLaren, R. S.,
S. F. Newbury,
G. S. C. Dance,
H. C. Causton, and C. F. Higgins.
1991.
mRNA degradation by processive 3'-to-5' exoribonucleases in vitro and the implications for prokaryotic mRNA decay in vivo.
J. Mol. Biol.
221:81-95[Medline].
|
| 25.
|
Miczak, A.,
V. R. Kaberdin,
C.-L. Wei, and S. Lin-Chao.
1996.
Proteins associated with RNase E in a multicomponent ribonucleolytic complex.
Proc. Natl. Acad. Sci. USA
93:3865-3869[Abstract/Free Full Text].
|
| 26.
|
Mitra, S., and D. H. Bechhofer.
1996.
In vitro processing activity of Bacillus subtilis polynucleotide phosphorylase.
Mol. Microbiol.
19:329-342[Medline].
|
| 27.
|
Py, B.,
H. Causton,
E. A. Mudd, and C. F. Higgins.
1994.
A protein complex mediating mRNA degradation in Escherichia coli.
Mol. Microbiol.
14:717-729[Medline].
|
| 28.
|
Shivakumar, A. G., and D. Dubnau.
1981.
Characterization of a plasmid-specified ribosome methylase associated with macrolide resistance.
Nucleic Acids Res.
9:2549-2562[Abstract/Free Full Text].
|
| 29.
|
Srivastava, S. K.,
V. J. Cannistraro, and D. Kennell.
1992.
Broad-specificity endoribonucleases and mRNA degradation in Escherichia coli.
J. Bacteriol.
174:56-62[Abstract/Free Full Text].
|
| 30.
|
Vazquez-Cruz, C., and G. Olmedo-Alvarez.
1997.
Mechanism of decay of the cry1Aa mRNA in Bacillus subtilis.
J. Bacteriol.
179:6341-6348[Abstract/Free Full Text].
|
| 31.
|
Villafane, R.,
D. H. Bechhofer,
C. S. Narayanan, and D. Dubnau.
1987.
Replication control genes of plasmid pE194.
J. Bacteriol.
169:4822-4829[Abstract/Free Full Text].
|
| 32.
|
Wang, W., and D. H. Bechhofer.
1996.
Properties of a Bacillus subtilis polynucleotide phosphorylase deletion strain.
J. Bacteriol.
178:2375-2382[Abstract/Free Full Text].
|
| 33.
|
Wang, W., and D. H. Bechhofer.
1997.
Bacillus subtilis RNase III gene: cloning, function of the gene in Escherichia coli, and construction of Bacillus subtilis strains with altered rnc loci.
J. Bacteriol.
179:7379-7385[Abstract/Free Full Text].
|
| 33a.
| Wang, W., and D. H. Bechhofer. Unpublished
data.
|
| 34.
|
Weisblum, B.
1983.
Inducible resistance to macrolides, lincosamides and streptogramin B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression, p. 91-121.
In
J. Beckwith, J. Davies, and J. A. Gallant (ed.), Gene function in prokaryotes. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
Journal of Bacteriology, November 1998, p. 5968-5977, Vol. 180, No. 22
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fujinami, S., Sato, T., Trimmer, J. S., Spiller, B. W., Clapham, D. E., Krulwich, T. A., Kawagishi, I., Ito, M.
(2007). The voltage-gated Na+ channel NaVBP co-localizes with methyl-accepting chemotaxis protein at cell poles of alkaliphilic Bacillus pseudofirmus OF4. Microbiology
153: 4027-4038
[Abstract]
[Full Text]
-
McGraw, A. P., Bevilacqua, P. C., Babitzke, P.
(2007). TRAP-5' stem loop interaction increases the efficiency of transcription termination in the Bacillus subtilis trpEDCFBA operon leader region. RNA
13: 2020-2033
[Abstract]
[Full Text]
-
Wang, W., Pearson, M. M., Attia, A. S., Blick, R. J., Hansen, E. J.
(2007). A UspA2H-Negative Variant of Moraxella catarrhalis Strain O46E Has a Deletion in a Homopolymeric Nucleotide Repeat Common to uspA2H Genes. Infect. Immun.
75: 2035-2045
[Abstract]
[Full Text]
-
Oussenko, I. A., Abe, T., Ujiie, H., Muto, A., Bechhofer, D. H.
(2005). Participation of 3'-to-5' Exoribonucleases in the Turnover of Bacillus subtilis mRNA. J. Bacteriol.
187: 2758-2767
[Abstract]
[Full Text]
-
Condon, C.
(2003). RNA Processing and Degradation in Bacillus subtilis. Microbiol. Mol. Biol. Rev.
67: 157-174
[Abstract]
[Full Text]
-
Oussenko, I. A., Sanchez, R., Bechhofer, D. H.
(2002). Bacillus subtilis YhaM, a Member of a New Family of 3'-to-5' Exonucleases in Gram-Positive Bacteria. J. Bacteriol.
184: 6250-6259
[Abstract]
[Full Text]
-
Pereira, Y., Chambert, R., Leloup, L., Daguer, J.-P., Petit-Glatron, M.-F.
(2001). Transcripts of the genes sacB, amyE, sacC and csn expressed in Bacillus subtilis under the control of the 5' untranslated sacR region display different stabilities that can be modulated. Microbiology
147: 1331-1341
[Abstract]
[Full Text]
-
Oussenko, I. A., Bechhofer, D. H.
(2000). The yvaJ Gene of Bacillus subtilis Encodes a 3'-to-5' Exoribonuclease and Is Not Essential in a Strain Lacking Polynucleotide Phosphorylase. J. Bacteriol.
182: 2639-2642
[Abstract]
[Full Text]
-
Wang, W., Guffanti, A. A., Wei, Y., Ito, M., Krulwich, T. A.
(2000). Two Types of Bacillus subtilis tetA(L) Deletion Strains Reveal the Physiological Importance of TetA(L) in K+ Acquisition as well as in Na+, Alkali, and Tetracycline Resistance. J. Bacteriol.
182: 2088-2095
[Abstract]
[Full Text]
-
Farr, G. A., Oussenko, I. A., Bechhofer, D. H.
(1999). Protection against 3'-to-5' RNA Decay in Bacillus subtilis. J. Bacteriol.
181: 7323-7330
[Abstract]
[Full Text]
-
Sudershana, S., Du, H., Mahalanabis, M., Babitzke, P.
(1999). A 5' RNA Stem-Loop Participates in the Transcription Attenuation Mechanism That Controls Expression of the Bacillus subtilis trpEDCFBA Operon. J. Bacteriol.
181: 5742-5749
[Abstract]
[Full Text]